Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHELLE ERAZO

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner

NPI
1306556618
CMS profile
11414976
Location
SAN DIEGO, CA

General Payments · PY2024

$263.08

  • Reported across 18 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$263.08

18 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $263.08 18

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Neurocrine BioSciences, Inc. $161.64 17
Novo Nordisk AS $101.44 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2024 $263.08 18

Payment records · PY2024 (18)

Sorted by paying entity, then date · as published by CMS

Program year 2024
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Neurocrine Biosciences, Inc. $22.22 03/16/2024 Food and Beverage Undisputed 01/23/2026 1150968347 CMS
Neurocrine Biosciences, Inc. $5.90 03/16/2024 Food and Beverage Undisputed 01/23/2026 1151021870 CMS
Neurocrine Biosciences, Inc. $6.22 05/24/2024 Food and Beverage Undisputed 01/23/2026 1151021086 CMS
Neurocrine Biosciences, Inc. $18.85 05/26/2024 Food and Beverage Undisputed 01/23/2026 1150985619 CMS
Neurocrine Biosciences, Inc. $17.40 06/18/2024 Food and Beverage Undisputed 01/23/2026 1150992764 CMS
Neurocrine Biosciences, Inc. $1.92 06/19/2024 Food and Beverage Undisputed 01/23/2026 1151027616 CMS
Neurocrine Biosciences, Inc. $13.61 07/11/2024 Food and Beverage Undisputed 01/23/2026 1151008903 CMS
Neurocrine Biosciences, Inc. $6.46 07/11/2024 Food and Beverage Undisputed 01/23/2026 1151020418 CMS
Neurocrine Biosciences, Inc. $16.69 11/12/2024 Food and Beverage Undisputed 01/23/2026 1150996432 CMS
Neurocrine Biosciences, Inc. $2.48 11/15/2024 Food and Beverage Undisputed 01/23/2026 1151026969 CMS
Neurocrine Biosciences, Inc. $14.88 11/25/2024 Food and Beverage Undisputed 01/23/2026 1151004536 CMS
Neurocrine Biosciences, Inc. $10.03 11/25/2024 Food and Beverage Undisputed 01/23/2026 1151014762 CMS
Neurocrine Biosciences, Inc. $1.68 11/25/2024 Food and Beverage Undisputed 01/23/2026 1151027942 CMS
Neurocrine Biosciences, Inc. $2.32 12/13/2024 Food and Beverage Undisputed 01/23/2026 1151027148 CMS
Neurocrine Biosciences, Inc. $12.17 12/14/2024 Food and Beverage Undisputed 01/23/2026 1151012015 CMS
Neurocrine Biosciences, Inc. $8.46 12/14/2024 Food and Beverage Undisputed 01/23/2026 1151016815 CMS
Neurocrine Biosciences, Inc. $0.35 12/14/2024 Food and Beverage Undisputed 01/23/2026 1151029438 CMS
Novo Nordisk Inc $101.44 02/05/2024 Food and Beverage Undisputed 01/23/2026 1100278908 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2024
Source files
Dataset page · Bulk file · PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.